Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03031665 · ClinicalTrials.gov registry record
Sex, Hormones and Gamma-Aminobutyric Acid (GABA) in Stress Induced Anhedonia in Depression
A clinical trial, sponsored by Mclean Hospital.
- Completed
- Registry status
- 251
- Enrollment target
NCT03031665 is a clinical trial that has completed, run by Mclean Hospital. The registered enrollment target is 251 participants.
The verdict
NCT03031665 has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- 251 participants
- Enrollment target
Study Summary
Using an innovative multi-modal imaging approach, this study investigates the role of the neurochemical gamma-aminobutyric acid (GABA), brain activity, as well as hormones in understanding sex differences in Major Depressive Disorder (MDD). Further, the investigators will link these markers to symptoms of depression.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2022-06-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03031665
The ClinicalTrials.gov registry entry for NCT03031665 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03031665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03031665 about?
NCT03031665 is a clinical study titled "Sex, Hormones and Gamma-Aminobutyric Acid (GABA) in Stress Induced Anhedonia in Depression". Using an innovative multi-modal imaging approach, this study investigates the role of the neurochemical gamma-aminobutyric acid (GABA), brain activity, as well as hormones in understanding sex differences in Major Depressive Disorder (MDD). Further, the investigators will link these markers to sympt...
What is the current status of trial NCT03031665?
This trial is currently completed. The enrollment target is 251 participants. The study started on 2017-10-01. Estimated completion is 2022-06-15.
Who is sponsoring clinical trial NCT03031665?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.